Market Cap: $3.87B
AC
Adaptive Biotechnologies Corporation
ADPT
NASDAQ (NASDAQ Global Select)USD
Market Cap: $3.87B
Filed a patent for "uniquely tagged rearranged adaptive immune receptor genes in a complex gene set" on Thu, July 27, 2023
New US PatentFiled a patent for "therapeutic t-cell receptors targeting kras g12d" on Mon, February 27, 2023
New US PatentFiled a patent for "synthetic strands for nucleic acid sequencing and related methods and systems" on Thu, February 15, 2024
New US PatentFiled a patent for "determining wt-1-specific t cells and wt-1 specific t cell receptors (tcrs)" on Thu, February 9, 2023
New US Patent